phase readout
saveNCT03439137: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
COMPLETEDupdated 2mo ago
community read0 votes
Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Hemodialysis Dependent Chronic Kidney Disease
view source ↗
comments(0)
5-min edit window · permanent after that